Salinomycin exerts anti‐colorectal cancer activity by targeting the β‐catenin/T‐cell factor complex

Abstract

Our study suggested that salinomycin could suppress the growth of colorectal cancer by disrupting the β-catenin/TCF complex and thus may be a promising agent for colorectal cancer treatment.